{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:05:26Z","timestamp":1786975526589,"version":"build-2736575974"},"reference-count":0,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2018,1,9]]},"DOI":"10.1001\/jama.2017.20189","type":"journal-article","created":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T09:40:59Z","timestamp":1515577259000},"page":"188","source":"Crossref","is-referenced-by-count":27,"title":["Lesinurad\/Allopurinol (Duzallo) for Gout-Associated Hyperuricemia"],"prefix":"10.1001","volume":"319","member":"10","container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/jama.jamanetwork.com\/article.aspx?doi=10.1001\/jama.2017.20189","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T09:40:59Z","timestamp":1515577259000},"score":1,"resource":{"primary":{"URL":"http:\/\/jama.jamanetwork.com\/article.aspx?doi=10.1001\/jama.2017.20189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,9]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,1,9]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2017.20189","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1,9]]}}}